Smoking and Health: Report of the Advisory Committee to the Surgeon General of the United States

Carnegie Mellon Trustee Ray Lane and Stephanie Lane Invest $25 Million in CMU's Computational Biology Department

Retrieved on: 
Monday, November 6, 2023
Faculty, Lawrence Hall of Science, Hewlett-Packard, CMU, Carnegie Mellon University Computational Biology Department, Bio-economy Research and Technology Council, Life, Ray, Computational biology, Data science, Mellon College of Science, Multimedia, Carnegie Mellon School of Computer Science, International Society for Nanoscale Science, Computation, and Engineering, Growth, School, 14th Annual Interactive Achievement Awards, Statistics, Student, Lane, Machine learning, Smoking and Health: Report of the Advisory Committee to the Surgeon General of the United States, Forbes Avenue, Kleiner Perkins, Computer, Algorithm, IBM, Biology, Parent, Computer science, Industrial design, Management, Carnegie Mellon University, Oracle

PITTSBURGH, Nov. 6, 2023 /PRNewswire/ -- Carnegie Mellon University Trustee Ray Lane and his wife, Stephanie, have invested $25 million in support of the university's boundary-breaking Computational Biology Department. The gift will establish an endowment to support the program's strategic priorities and provide the funding for its future home in the new Richard King Mellon Hall of Sciences

Key Points: 
  • PITTSBURGH, Nov. 6, 2023 /PRNewswire/ -- Carnegie Mellon University Trustee Ray Lane and his wife, Stephanie, have invested $25 million in support of the university's boundary-breaking Computational Biology Department.
  • In recognition of the couple's significant role in shaping computational biology at Carnegie Mellon, the university will name the department the Ray and Stephanie Lane Computational Biology Department.
  • "Ray and Stephanie Lane have been passionate advocates for the power and possibilities of computational biology since the department's formation," said CMU President Farnam Jahanian.
  • The Lanes made their initial investment in computational biology at CMU to establish the Ray and Stephanie Lane Professorship in Computational Biology, the Ray and Stephanie Lane Post-Doctoral Program in Computational Biology and the Raymond Lane Fellowship in Computational Biology.

Zymeworks Announces New Director Nominee

Retrieved on: 
Monday, October 16, 2023
Gene expression, Cancer, Internal medicine, Biology, Breast cancer, AACR, Apoptosis, Society, Cyber Security Collaborative Research Alliance, IND, University of Washington Department of Global Health, Fred Hutchinson Cancer Research Center, University, National Cancer Institute, Wellesley College, Disease, Hormone, Johns Hopkins Hospital, American Association for Cancer Research, Johns Hopkins, Harvard Medical School, Publication, Executive, ASCO, Molecular biology, Woman, Patient, Smoking and Health: Report of the Advisory Committee to the Surgeon General of the United States, Pharmaceutical industry, MD, Zymeworks

“With this in mind, we are delighted to invite Dr. Davidson to join our board of directors.

Key Points: 
  • “With this in mind, we are delighted to invite Dr. Davidson to join our board of directors.
  • Her lab studies have paved the way for new clinical trials of drugs that exploit these pathways to kill breast cancer.
  • Prior to joining FHCC, she spent time at the National Cancer Institute, Johns Hopkins in Baltimore and the University of Pittsburgh.
  • Dr. Davidson completed her residency in Internal Medicine at John Hopkins Hospital and a fellowship at the National Cancer Institute.

EmVenio Research continues momentum of team growth with two new principal investigators

Retrieved on: 
Thursday, September 21, 2023
Molecular biology, Doctor of Medicine, University, Diabetes, Internal medicine, Smoking and Health: Report of the Advisory Committee to the Surgeon General of the United States, Physician, American Board of Internal Medicine, Georgetown University School of Medicine, Cardiovascular disease, Infection, University School, Physiology, DRS, Research, Georgetown University, American Board of Commissioners for Foreign Missions, Health care access among Dalits in India, Indiana University School of Medicine, Surgeon, Accreditation, Knowledge, Growth, Jan Vansina, National Board of Medical Examiners, Pharmaceutical industry, Medical device, Nursing, Science, Indiana University

DURHAM, N.C., Sept. 21, 2023 /PRNewswire/ -- Clinical research organization EmVenio Research recently announced the addition of Michelle Mallitz, M.D. and Thomas Wade, M.D. to its team to serve as principal investigators. In their roles, they will oversee and conduct objective clinical research to ensure independent, high quality and reproducible results, as well as manage oversight of compliance, financial, personnel and other related aspects of research projects. Coming from varying medical backgrounds, Drs. Mallitz and Wade bring a depth of knowledge and experience to the EmVenio team, allowing the research organization to conduct trials addressing a wider range of infectious diseases and therapeutic areas.

Key Points: 
  • DURHAM, N.C., Sept. 21, 2023 /PRNewswire/ -- Clinical research organization EmVenio Research recently announced the addition of Michelle Mallitz, M.D.
  • "The addition of these two incredible principal investigators is proof that EmVenio's growth is focused on quality and not quantity," said Thad Wolfram, EmVenio president.
  • "These individuals bring a level of expertise and skill that opens more doors for our team to conduct a multitude of research studies for pharmaceutical sponsors and clinical research organizations.
  • Dr. Thomas Wade holds nearly 23 years of medical practice and clinical research experience, serving as a principal investigator and practicing internal medicine.

Children’s Hospital Los Angeles Names Sucheta Joshi, MD, MS, FAAP, FAES as Incoming Medical Director of Comprehensive Epilepsy Program

Retrieved on: 
Thursday, June 29, 2023
Health, Hospitals, Epilepsy, Seth, Telehealth, Bachelor, University of Mumbai, University, MBBS, National Association of Epilepsy Centers, Bachelor of Medicine, Bachelor of Surgery, CHLA, Policy, Advisory Committee, Pediatrics (journal), King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College, Service, American Academy, Multimedia, AAP, Research, Neurology, Montreal Neurological Institute and Hospital, Smoking and Health: Report of the Advisory Committee to the Surgeon General of the United States, Stanford University School of Medicine, University of Michigan School of Dentistry, Michigan Medicine, Pediatric Neurology, Public health, Committee, Medical director, Division, Children's Hospital Los Angeles, FAES, University of Michigan School of Public Health, National Association, Nursing, Pharmaceutical industry, Pediatrics, FAAP, MD, Medicine

View the full release here: https://www.businesswire.com/news/home/20230629162494/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230629162494/en/
    Sucheta Joshi, MD, MS, FAAP, FAES, has been named as incoming Medical Director of the Neurological Institute Comprehensive Epilepsy Program at Children’s Hospital Los Angeles (CHLA).
  • She most recently has served as Service Chief of Pediatric Neurology and Medical Director of Pediatric Epilepsy at Michigan Medicine, the academic medical center of the University of Michigan, where she launched a complex epilepsy clinical program and an inpatient pediatric epilepsy service.
  • In her new role, Dr. Joshi will lead and expand the Comprehensive Epilepsy Program at CHLA and will grow programs such as telehealth, precision health trials, adult transition, team-based clinics and surgical epilepsy.
  • Joshi’s leadership will help us reach the full potential of our Comprehensive Epilepsy Program.

Kurome Therapeutics Announces Oral and Poster Presentations on Dual IRAK1/4 Inhibitors at American Society of Hematology Annual Meeting

Retrieved on: 
Tuesday, December 6, 2022
Oncology, Health, Research, Pharmaceutical, Science, Biotechnology, Therapy, Exposition, Ecklonia kurome, BS, Cincinnati Children's Hospital Medical Center, National Center for Advancing Translational Sciences, Doctor of Philosophy, Pharmacology, Society, 2021 Essex County Council election, Smoking and Health: Report of the Advisory Committee to the Surgeon General of the United States, Cancer, Acute myeloid leukemia, MS, Lead, IRAK1, AML, Myelodysplastic syndrome, National Institutes of Health, MDS, Drug resistance, ASH, Pharmaceutical industry, Vaccine

Kurome Therapeutics, Inc., a late pre clinical stage biotech company developing novel IRAK1/4 inhibitors for oncology indications, today announced two abstracts have been accepted for oral and poster presentations at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition, to be held December 9-13, 2022, in New Orleans.

Key Points: 
  • Kurome Therapeutics, Inc., a late pre clinical stage biotech company developing novel IRAK1/4 inhibitors for oncology indications, today announced two abstracts have been accepted for oral and poster presentations at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition, to be held December 9-13, 2022, in New Orleans.
  • The presentations highlight preclinical data supporting the importance of inhibiting both IRAK1 and IRAK4 in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS).
  • Kurome is developing a series of potent IRAK1/4 and panFLT3 inhibitors that work by targeting key cancer survival pathways.
  • The companys first to market indications will be Acute Myeloid Leukemia (AML) and high-risk MDS.

Campaign for Safe Cosmetics Publishes First-Ever List of Top Non-Toxic Black-Owned Beauty Brands & Product Database

Retrieved on: 
Tuesday, October 18, 2022
SAN, Movement, Disease, Risk, Woman, Maternal health, Organization, Beauty Brands, Campaign for Safe Cosmetics, Health equity, Program, Advisory Committee, CSC, Mortality, Breast cancer, Cancer, Awareness, Hair, Health, Campaign, Ectopic pregnancy, Breast, Safety, Diabetes, Endometriosis, Smoking and Health: Report of the Advisory Committee to the Surgeon General of the United States, GLOBE, Infertility, Uterine fibroid, Database, Beauty, Lead, Breast Cancer Awareness Month, Cosmetics, Birth control, Cosmetics, Black

This project brings health equity to the forefront by providing a database of clean beauty products to help Black women and girls live their healthiest lives and prevent breast cancer.

Key Points: 
  • This project brings health equity to the forefront by providing a database of clean beauty products to help Black women and girls live their healthiest lives and prevent breast cancer.
  • CSC's Top Non-Toxic Black Beauty Brands 2022 > CSC'sNon-Toxic Black Beauty Product Database >
    Released during Breast Cancer Awareness Month, the Non-Toxic Black Beauty Project focuses specifically on supporting Black women's health because Black women face the highest breast cancer mortality rate of any racial or ethnic group in America.
  • Beauty products marketed to Black women often contain the most toxic cosmetics ingredients, including chemicals linked to cancer.
  • "We are thrilled to announce the launch of our searchable database of non-toxic Black beauty products," said Janet Nudelman, Director of the Campaign for Safe Cosmetics, a program of Breast Cancer Prevention Partners.

The Former Director of the Center for Drug Evaluation and Research at FDA, Steven Galson, Joins Elephas as Independent Director

Retrieved on: 
Thursday, July 28, 2022
Association, Executive Committee, Harvard School of Dental Medicine, BioCryst Pharmaceuticals, Icahn School of Medicine at Mount Sinai, Clinical trial, Center, Africa/Harvard School of Public Health Partnership for Cohort Research and Training, Public health, Center for Drug Evaluation and Research, Drug discovery, CEO, Stony Brook University, Artificial intelligence, National academy, Amgen, Board, Drexel University School of Public Health, Multimedia, Keck Graduate Institute, Cancer, Insilico Medicine, Medal, Leadership, Director, Drug development, FDA, CDER, Patient, LinkedIn, Commission, Surgeon, Smoking and Health: Report of the Advisory Committee to the Surgeon General of the United States, Hope, Face, Public service, Popular Executive Committee of Valencia, National Academy of Medicine, Pharmaceutical industry, Research, Elephas

Dr. Galson is a consultant to Amgen and serves on the Board of Directors of Insilico Medicine and Biocryst Pharmaceuticals.

Key Points: 
  • Dr. Galson is a consultant to Amgen and serves on the Board of Directors of Insilico Medicine and Biocryst Pharmaceuticals.
  • "I chose to join Elephas because they are developing a platform that will increase access to effective cancer therapies.
  • I am excited to help a team focused on making a positive difference in cancer patients' lives," stated Dr. Galson.
  • Previously, he served as Director of the FDA's Center for Drug Evaluation and Research (CDER), where he provided leadership for the center's broad national and international programs in pharmaceutical regulation.

THE HOWARD AND GEORGEANNA JONES FOUNDATION FOR REPRODUCTIVE MEDICINE ANNOUNCES FOUR NEW MEDICAL ADVISORY COMMITTEE MEMBERS

Retrieved on: 
Thursday, July 7, 2022
Department, III, Bioethics, Reproductive health, University, Research, Adult, Perelman School of Medicine at the University of Pennsylvania, Reproductive medicine, Smoking and Health: Report of the Advisory Committee to the Surgeon General of the United States, Gynaecology, MHS, Endocrinology, Multimedia, Obstetrics, Assistant professor, NIH, W. Alton Jones Foundation, Public policy, Education, Department of Obstetrics and Gynecology (Massachusetts General Hospital), Doctor of Philosophy, Foundation, Solution, Family, Board, Fertility, NICHD, Physician, MD, Howard, Pharmaceutical industry, Management, Birth control, Hospital, Program, DRS, Infertility

Anish A. Shah, MD, MHS, Executive Growth Physician, US Fertility and Practice Director, Reproductive Endocrinology and Infertility, Shady Grove Fertility Jones Institute.

Key Points: 
  • Anish A. Shah, MD, MHS, Executive Growth Physician, US Fertility and Practice Director, Reproductive Endocrinology and Infertility, Shady Grove Fertility Jones Institute.
  • The Jones Foundation is a non-profit organization dedicated to advancing scientific and medical research in the field of reproductive medicine.
  • Mr. Jones further commented that, "The Howard and Georgeanna Jones Foundation for Reproductive Medicine is the nation's preeminent medical research foundation in reproductive medicine.
  • The Howard and Georgeanna Jones Foundation for Reproductive Medicine is a 501(c)(3) organization that solicits funds from the general public to support scientific and medical research and education in the field of reproductive medicine.

Board Certified Vascular Surgeon Joins NDA Partners as Expert Consultant

Retrieved on: 
Wednesday, May 11, 2022
Smoking and Health: Report of the Advisory Committee to the Surgeon General of the United States, Economics, Society, Division, Gyles Mackrell, Wound healing, Pharmacokinetics, LLC, Greater Baltimore Medical Center, Biotechnology, NDA, Georgetown University School of Medicine, Toxicology, NewYork-Presbyterian Hospital, Trauma, Greenville Memorial Hospital, Program, Weill Cornell Medicine, Degenerative disease, Hospital, Princeton University, Partner, MD, Moyamoya disease, General surgery, CMC, USP, Society for Vascular Surgery, Dentistry, Sinai Hospital

WASHINGTON, May 11, 2022 /PRNewswire-PRWeb/ -- NDA Partners General Manager, Eric Fish, announced today that Peter Mackrell, MD, a board certified vascular surgeon, has joined the company as an Expert Consultant. Dr. Mackrell is a practicing surgeon with Vascular Surgery Associates, LLC and serves as Chief of the Division of Vascular Surgery and Co-Director of the Non-invasive Vascular Lab at the Greater Baltimore Medical Center and Sinai Hospital of Baltimore. He is an expert in peripheral arterial disease, venous disease, general surgery, trauma, wound healing, and cardiovascular percutaneous interventions and formerly served as Co-Director of the wound care center at the Greater Baltimore Medical Center. He is a member of the Society for Vascular Surgery and serves on advisory committees at the Greater Baltimore Medical Center and Cardiovascular Institute Council of the Sinai Hospital of Baltimore.

Key Points: 
  • NDA Partners General Manager, Eric Fish, announced today that Peter Mackrell, MD, a board certified vascular surgeon, has joined the company as an Expert Consultant.
  • Dr. Mackrell is a practicing surgeon with Vascular Surgery Associates, LLC and serves as Chief of the Division of Vascular Surgery and Co-Director of the Non-invasive Vascular Lab at the Greater Baltimore Medical Center and Sinai Hospital of Baltimore.
  • WASHINGTON, May 11, 2022 /PRNewswire-PRWeb/ -- NDA Partners General Manager, Eric Fish, announced today that Peter Mackrell, MD , a board certified vascular surgeon, has joined the company as an Expert Consultant.
  • Dr. Mackrell is a practicing surgeon with Vascular Surgery Associates, LLC and serves as Chief of the Division of Vascular Surgery and Co-Director of the Non-invasive Vascular Lab at the Greater Baltimore Medical Center and Sinai Hospital of Baltimore.

USOSM Salutes Dr. Wendell “Wedge” Edgin for 42 years of clinical practice, as he announces his intention to retire

Retrieved on: 
Thursday, April 28, 2022
International College, American Association of Oral and Maxillofacial Surgeons, Intention, Zoology, Family, Program, CEO, Davis–Monthan Air Force Base, Surgeon, Association, Texas Hill Country, Patient, Microbiology, GLOBE, Education, Air force, Texas Society of Architects, Student, Associate, OMS, University, International College of Dentists, American Association, Meritorious Service Medal, Oral and maxillofacial surgery, United, Smoking and Health: Report of the Advisory Committee to the Surgeon General of the United States, Legion, Oral, Texas Tech University, University of Texas System, The, Industry, DDS, American Board of Commissioners for Foreign Missions, American College, Private practice, Dentistry, Medicine, Dentist

IRVING, Texas, April 28, 2022 (GLOBE NEWSWIRE) -- After 42 years of clinical practice, Wendell Wedge Edgin, DDS, FICD, FACD, has announced his intention to retire from Alamo Maxillofacial Surgical Associates, effective May 1, 2022.

Key Points: 
  • IRVING, Texas, April 28, 2022 (GLOBE NEWSWIRE) -- After 42 years of clinical practice, Wendell Wedge Edgin, DDS, FICD, FACD, has announced his intention to retire from Alamo Maxillofacial Surgical Associates, effective May 1, 2022.
  • Oral Surgery Management (USOSM), with three locations, treating patients in San Antonio and Boerne, Texas.
  • This will be a big change for me and my family, but getting to spend more time together is something were looking forward to, said Dr. Edgin.
  • He is well-known throughout the Texas Hill Country and the oral and maxillofacial surgery (OMS) industry for his dedication, experience and clinical expertise.